Icahn School Of Medicine At Mount Sinai - Net Worth and Insider Trading
Icahn School Of Medicine At Mount Sinai Net Worth
The estimated net worth of Icahn School Of Medicine At Mount Sinai is at least $213 Million dollars as of 2024-11-29. Icahn School Of Medicine At Mount Sinai is the 10% Owner of GeneDx Holdings Corp and owns about 2,719,692 shares of GeneDx Holdings Corp (WGS) stock worth over $213 Million. Details can be seen in Icahn School Of Medicine At Mount Sinai's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Icahn School Of Medicine At Mount Sinai has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Icahn School Of Medicine At Mount Sinai
Icahn School Of Medicine At Mount Sinai Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Icahn School Of Medicine At Mount Sinai owns 2 companies in total, including GeneDx Holdings Corp (WGS) , and Renalytix PLC (RNLXY) .
Insider Ownership Summary of Icahn School Of Medicine At Mount Sinai
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2024-10-31 | 10 percent owner |
| RNLXY | Renalytix PLC | 2023-07-01 | 10 percent owner |
Icahn School Of Medicine At Mount Sinai Latest Holdings Summary
Icahn School Of Medicine At Mount Sinai currently owns a total of 1 stock. Icahn School Of Medicine At Mount Sinai owns 2,719,692 shares of GeneDx Holdings Corp (WGS) as of November 18, 2024, with a value of $213 Million.
Latest Holdings of Icahn School Of Medicine At Mount Sinai
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2024-11-18 | 2,719,692 | 78.39 | 213,196,656 |
Holding Weightings of Icahn School Of Medicine At Mount Sinai
Icahn School Of Medicine At Mount Sinai Form 4 Trading Tracker
According to the SEC Form 4 filings, Icahn School Of Medicine At Mount Sinai has made a total of 4 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in GeneDx Holdings Corp is the sale of 147,141 shares on November 18, 2024, which brought Icahn School Of Medicine At Mount Sinai around $10 Million.
Insider Trading History of Icahn School Of Medicine At Mount Sinai
- 1
Icahn School Of Medicine At Mount Sinai Trading Performance
GuruFocus tracks the stock performance after each of Icahn School Of Medicine At Mount Sinai's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Icahn School Of Medicine At Mount Sinai is -32.84%. GuruFocus also compares Icahn School Of Medicine At Mount Sinai's trading performance to market benchmark return within the same time period. The performance of stocks bought by Icahn School Of Medicine At Mount Sinai within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Icahn School Of Medicine At Mount Sinai's insider trading performs compared to the benchmark.
Performance of Icahn School Of Medicine At Mount Sinai
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.51 | | | | | |
| Relative Return to S&P 500(%) | 6.57 | | | | | |
Icahn School Of Medicine At Mount Sinai Ownership Network
Icahn School Of Medicine At Mount Sinai Owned Company Details
What does GeneDx Holdings Corp do?
Who are the key executives at GeneDx Holdings Corp?
Icahn School Of Medicine At Mount Sinai is the 10 percent owner of GeneDx Holdings Corp. Other key executives at GeneDx Holdings Corp include Chief Financial Officer Kevin Feeley , director & Chief Executive Officer Katherine Stueland , and 10 percent owner Opko Health, Inc. .
GeneDx Holdings Corp (WGS) Insider Trades Summary
Over the past 18 months, Icahn School Of Medicine At Mount Sinai made 2 insider transaction in GeneDx Holdings Corp (WGS) with a net sale of 1,012,941. Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 47,382 shares made by Kevin Feeley , a net sale of 127,500 shares made by Katherine Stueland , and a net sale of 9,890 shares made by Kareem Saad .
In summary, during the past 3 months, insiders sold 1,147,716 shares of GeneDx Holdings Corp (WGS) in total and bought 0 shares, with a net sale of 1,147,716 shares. During the past 18 months, 3,042,611 shares of GeneDx Holdings Corp (WGS) were sold and 560,642 shares were bought by its insiders, resulting in a net sale of 2,481,969 shares.
GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
GeneDx Holdings Corp Insider Transactions
Icahn School Of Medicine At Mount Sinai Mailing Address
Above is the net worth, insider trading, and ownership report for Icahn School Of Medicine At Mount Sinai. You might contact Icahn School Of Medicine At Mount Sinai via mailing address: 1 Gustave L. Levy Place, New York Ny 10029.
Discussions on Icahn School Of Medicine At Mount Sinai
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
